A baker’s dozen of HR teams at leading companies have been named finalists for the 2025 HR Icons Awards. All will be honored in September for their outstanding achievements leading workplace ...
Bristol Myers Squibb’s efforts to diversify its cancer portfolio beyond immunotherapies brought radiopharmaceuticals to its pipeline. Now it’s expanding its radiopharmaceuticals scope to ...
BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb ...
Cytokinetics aims to compete with a Bristol Myers Squibb heart drug projected to become a blockbuster seller, and the company’s value proposition is that its drug candidate has a ...